PUBLICATION

1    Pengjam Y, Semsri S, Wanram S, , Amarasakulsab T, Nateewaranart S, Hemhorm P. 2004. Evaluation of newly developed one tube methemoglobin reduction test as the reagent kit for G-6-PD deficiency screening. Bull Chiang Mai Assoc Med Sci. 37 (3): 168-174.

2    Pengjam Y, Hemhorm P, Wanram S, Semsri S, Amarasakulsab T, Nateewaranart S,  et al. 2005.  A simplified diagnosis of a-thalassemia 1 (SEA-type) using a direct PCR on whole blood lysate. Bull Chiang Mai Assoc Med Sci. 38 (2): 116-123.

3    Butthep P, Wanram S, Pattanapanyasat K, Vattanaviboon P, Fucharoen S, Wilairat P. 2006. Cytoadherence between endothelial cells and P. falciparum infected and non-infected normal and thalassemic red blood cells. Cytometry B Clin Cytom. 70 (6): 432-42.

4    Hemhorm P, Wanram S, Karanan K, Likhit S, Thumkaew P,  Kaewma C, Pengjam Y. 2009. Evaluation of reticulocyte number counted by coulter HmX compared to coulter STKS and manual methods. Bull Chiang Mai Assoc Med Sci. 42 (1): 18-24.

5   Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Luanratanakorn S, and Jearanaikoon P. 2007. Development of method for integrated HPV16 detection in cervical carcinoma using multiplex quantitative PCR. Journal of Medical Technology and Physical Therapy 19 (1): 6-15 (Original article).

6   Jearanaikoon P, Nattasirikul N, Kaepo W, Wanram S, Leelayuwat C, Paupairoj A, and Limpaiboon T. 2007.  Tapasin expression in cervical carcinoma. Journal of Medical Technology and Physical Therapy 19 (1): 55-63 (Original article).

7  Jearanaikoon P, Kongmuangpuk N, Yodpratoom U, Wanram S, Leelayuwat C, Paupairoj A, and Limpaiboon T.  2007.  The alteration of MHC class I expression in cervical cancer.  Journal of Medical Technology and Physical Therapy 19 (2): 108-117 (Original article).

8  Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Guiney DG, Lulitanond V, Jearanaikoon P. 2009. The use of viral load as a surrogate marker in predicting disease progression for early invasive cervical cancer patients with integrated human papillomavirus type 16. Am J Obstet Gynecol. Jul; 201(1):79.e1-7.

9  Panomket P, Wanram S, and Srivoramas T. 2011. Antimicrobial activity of extracts of Thai plant to Burkholderia pseudomallei. Journal of Medical Technology and Physical Therapy 23(2): 151-158 (Original article).

10 Panomket P. Wanram S. 2011. “Hoan Ngoc activity in streptozotocin induced diabetic mice”, IJPS. 7(2): 22-28 (Original article).

11 Panomket P. Wanram S, Jittimanee J, Teerawatanasuk N, Nilsakul J, and Nuntalohit S. 2011. “Susceptibility of ceftazidime to Burkholderia pseudomallei found in patients in Sappasitprasong Hospital”. Journal of Medical Technology and Physical Therapy 23(3): (Original article). 

12 Wanram S. 2011. Therapeutic vaccinations against human papillomavirus associated with cervical cancer. Journal of Medical Technology and Physical Therapy 23(2): 116-127 (Review article). 

13 Wanram S, Panomket P, Datta S, Raz E, Limpaiboon T, Guiney DG and Jearanaikoon P. 2011. Study of g-irradiated Listeria monocytogenese-Ovalbumin as a vaccination with enhancements of activated charcoal platform. World Journal of Microbiology and Biotechnology (In progress).

14 Wanram S, Prasongdee P, Limpaiboon T, Puapairoj A, Yuenyao P, Leelayuwat C and Jearanaikoon P. 2011. High occurrence of mixed infection with human papillomavirus type 16 influences the use of HPV16 physical status for predicting cervical cancer progression in patients with pre-cancerous lesions. Am J Obstet Gynecol (In progress).

PRESENTATION:

15 Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Luanratanakorn S, and Jearanaikoon P. (2006, March 28-31).  Establishment of integrated HPV16 DNA in cervical cancer by qPCR. The 30^th annual congress on medical technology: Integrative mission for health promotion and quality of life, Udorn Thanee, Thailand (Poster presentation).

16 Jearanaikoon P, Kongmuangpuk N, Yodpratoom U, Wanram S, Leelayuwat C, Puapairoj A, and Limpaiboon T. (2006, July 8-12). Impaired MHC Class I antigen surface expression demonstrated as the major event for loss of immune surveillance in cervical cancer is unlikely due to down regulation of heavy chain and b₂M expression. The 19^th UICC world cancer congress, Washington, USA (Poster presentation).

17 Wanram S, Limpaiboon T, Leelayuwat C, Barusrux S, Lulitanond V, Paupairoj A, Yuenyao P, Luanratanakorn S, and Jearanaikoon P. (2007, January 18-19). Cervical cancer project and future directions: Research and Development. The KKU innovations 2007, Khon Kaen, Thailand (Poster presentation).

18 Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Luanratanakorn S, and Jearanaikoon P. (2007, April 21-22). The usage of human papillomavirus type 16 physical status in precancerous lesion and invasive cervical carcinoma of northern-east Thai women as prognostic marker in cervical cancer treatment.  The Lancet Asia Medical Forum 2007, Suntec, Singapore (Poster presentation).

19 Jearanaikoon P, Wanram S, Tussakhon I, Leelayuwat C, Paupairoj A, and Limpaiboon T.  The usage of expression profiles of p53, delta Np63, and delta Np73 as prognostic markers in invasive cervical carcinoma. The European Cancer conference14 (ECCO 14^th). 23-27 September, 2007. Barcelona, Spain (Poster presentation).

20 Prasongdee P, Limpaiboon T, Leelayuwat C, Wanram S, Promptmas C, and Jearanaikoon P. The development of biosensor prototype for human papillomavirus typing in cervical cancer patients. The 31^th annual congress on medical technology: 25-27 April, 2007. Lotus Hotel Pang Saun Kaew Chiengmai (Poster presentation).

21 Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Lulitanond V, Guiney DG, Jearanaikoon P. Prognostic significance of viral load and integrated HPV type 16 in predicting clinical outcome of cervical cancer. The 5^th International Asian Conference on Cancer Screening-IACCS. 10-11 SEP, 2008, Khon Kaen, Thailand (Poster presentation).

22 Wanram S, Puapairoj A, Leelayuwat C, Limpaiboon T, Jearanaikoon P. Alteration of MHC class I and antigen processing machinery by immunohistochemical staining during cervical development. The 5^th International Asian Conference on Cancer Screening-IACCS. 10-11 SEP, 2008, Khon Kaen, Thailand (Poster presentation: Poster Award).

23 Wanram S, Yuenyao P, Limpaiboon T, Leelayuwat C, Luanrattanakorn S, Jearanaikoon P. Prevalence of single and mixed high-risk HPV types during cervical development in Northeast-Thai woman. The 12^th Biennial Meeting International Gynecologic Cancer Society-IGCS 2008. 25-28 October, 2008, Bangkok, Thailand (Poster presentation).

24 Wanram S, Limpaiboon T, Leelayuwat T, Jearanaikoon P. The use of viral load as a surrogate marker in predicting disease progression for early invasive cervical cancer patients with integrated human papillomavirus type 16. The 2^nd CHE-Congress 2009. 27-29 October, Dhusit thane-Pattaya, Chonburi, Thailand (Poster presentation).

25 ดร.สุรศักดิ์ แว่นรัมย์, 2553. มารู้จักมะเร็งปากมดลูกกันเถอะ. จุลสารวิจัยวิทยาลัยแพทยศาสตร และการสาธารณสุข มหาวิทยาลัยอุบลราชธานี. ฉบับที่ 1 ปี 2553 (บทความวิชาการ)

26 ดร.สุรศักดิ์ แว่นรัมย์, 2554. โรคเลือดจางทางพันธุกรรม “ธาลัสซีเมีย”; ความสำคัญ แนวทางในการตรวจคัดกรอง การวินิจฉัย และการป้องกัน รักษา. เอกสารเผยแพร่บริการวิชาการฯ สังกัดวิทยาลัยแพทยศาสตร และการสาธารณสุข มหาวิทยาลัยอุบลราชธานี. โปสเตอร์นำเสนอที่ 1-8 ปี 2554